Diphenidol for levodopa induced nausea and vomiting

Review: neuropathology of acute phase encephalitis lethargica: a review of cases from the epidemic period.

Neuropathology and applied neurobiology·2009

Mutation in the alpha-synuclein gene identified in families with Parkinson's disease.

Science (New York, N.Y.)·1997

Mapping of a gene for Parkinson's disease to chromosome 4q21-q23.

Science (New York, N.Y.)·1996

Clinical genetic analysis of Parkinson's disease in the Contursi kindred.

Annals of neurology·1996

Follow-up study of risk factors in progressive supranuclear palsy.

Neurology·1996

Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop.

Neurology·1996

Prognostic Value of Blood-Based P-Tau217 Levels for Progression to Cognitive Impairment.

JAMA·2026

Ceperognastat in Early Symptomatic Alzheimer Disease: A Randomized Clinical Trial.

JAMA·2026

Amyloid PET Quantitation and Centiloid Thresholds in the Diagnosis of Alzheimer Disease: An Individual Participant Data Meta-Analysis.

JAMA·2026

Clinicopathologic Evaluation of Amyloid Clearance in Alzheimer Disease.

JAMA·2026

YEARS Algorithm for Diagnosis of Suspected Pulmonary Embolism in Patients With Cancer: A Randomized Clinical Trial.

JAMA·2026

Evaluation of brexpiprazole as adjunctive therapy in treatment-resistant depression: Real-world data.

Dusunen adam : Bakirkoy Ruh ve Sinir Hastaliklari Hastanesi yayin organi·2026

Unveiling the sumatriptan dose-relief relationship.

European journal of clinical pharmacology·2026

Comparison of Trough-Only and Peak-Trough Concentration Data for the Calculation of Vancomycin Area under the Concentration-Time Curve on Day 2 Using Previous and Updated Population Pharmacokinetic Models.

Biological & pharmaceutical bulletin·2026

Mapping Therapeutic Drug Monitoring Research in Low- and Middle-Income Countries: A Scoping Review (2015-2024).

Therapeutic drug monitoring·2026

Polymeric systems for peptide and protein delivery: design principles, translational barriers, and future research directions.

International journal of pharmaceutics·2026

Safety, tolerability, and efficacy of flexible-dose tavapadon for Parkinson's disease (TEMPO-2): a phase 3, randomised, placebo-controlled, double-blind trial.

The Lancet. Neurology·2026

Related Experiment Videos

Diphenidol for levodopa induced nausea and vomiting

Related Concept Videos

Review: neuropathology of acute phase encephalitis lethargica: a review of cases from the epidemic period.

Mutation in the alpha-synuclein gene identified in families with Parkinson's disease.

Mapping of a gene for Parkinson's disease to chromosome 4q21-q23.

Clinical genetic analysis of Parkinson's disease in the Contursi kindred.

Follow-up study of risk factors in progressive supranuclear palsy.

Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop.

Prognostic Value of Blood-Based P-Tau217 Levels for Progression to Cognitive Impairment.

Ceperognastat in Early Symptomatic Alzheimer Disease: A Randomized Clinical Trial.

Amyloid PET Quantitation and Centiloid Thresholds in the Diagnosis of Alzheimer Disease: An Individual Participant Data Meta-Analysis.

Clinicopathologic Evaluation of Amyloid Clearance in Alzheimer Disease.

YEARS Algorithm for Diagnosis of Suspected Pulmonary Embolism in Patients With Cancer: A Randomized Clinical Trial.

Evaluation of brexpiprazole as adjunctive therapy in treatment-resistant depression: Real-world data.

Unveiling the sumatriptan dose-relief relationship.

Comparison of Trough-Only and Peak-Trough Concentration Data for the Calculation of Vancomycin Area under the Concentration-Time Curve on Day 2 Using Previous and Updated Population Pharmacokinetic Models.

Mapping Therapeutic Drug Monitoring Research in Low- and Middle-Income Countries: A Scoping Review (2015-2024).

Polymeric systems for peptide and protein delivery: design principles, translational barriers, and future research directions.

Safety, tolerability, and efficacy of flexible-dose tavapadon for Parkinson's disease (TEMPO-2): a phase 3, randomised, placebo-controlled, double-blind trial.

Related Experiment Videos

Diphenidol for levodopa induced nausea and vomiting

Related Concept Videos

Related Articles